ICD-10-CM Code D81.39

Other adenosine deaminase deficiency

Version 2021 Billable Code

Valid for Submission

D81.39 is a billable code used to specify a medical diagnosis of other adenosine deaminase deficiency. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions.

ICD-10:D81.39
Short Description:Other adenosine deaminase deficiency
Long Description:Other adenosine deaminase deficiency

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D81.39:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Adenosine deaminase ADA deficiency type 1, NOS
  • Adenosine deaminase ADA deficiency type 1, without SCID
  • Adenosine deaminase ADA deficiency type 1, without severe combined immunodeficiency
  • Partial ADA deficiency (type 1)
  • Partial adenosine deaminase deficiency (type 1)

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D81.39 are found in the index:


Replacement Code

D8139 replaces the following previously assigned ICD-10 code(s):

  • D81.3 - Adenosine deaminase [ADA] deficiency

Code Classification

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
    • Certain disorders involving the immune mechanism (D80-D89)
      • Combined immunodeficiencies (D81)

Code History

  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021